Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/30/2003WO2003044171A2 Organelle-associated proteins
05/30/2003WO2003044166A2 METHODS AND COMPOSITIONS FOR REGULATION OF GENE EXPRESSION THROUGH MODULATION OF mRNA TURNOVER
05/30/2003WO2003044162A2 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003WO2003044160A2 Novel molecules of the card related protein family and uses thereof
05/30/2003WO2003044159A2 Zinc finger proteins, polynucleotides encoding same and antibodies thereto
05/30/2003WO2003044059A1 Agonists of recombinant human histamine h3 receptor
05/30/2003WO2003044056A2 Chemically-modified human growth hormone conjugates
05/30/2003WO2003044055A1 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines
05/30/2003WO2003044054A2 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases
05/30/2003WO2003044053A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/30/2003WO2003044052A1 Antifreeze proteins originating in fishes
05/30/2003WO2003044051A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
05/30/2003WO2003044050A1 Method for producing a recombinant protein using pollen
05/30/2003WO2003044049A1 Antimicrobial polypeptides from pseudoplectania nigrella
05/30/2003WO2003044048A2 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen
05/30/2003WO2003044047A2 Virulence proteins of the genus yersinia and uses thereof
05/30/2003WO2003044044A1 Novel peptide having angiotensin convertase inhibitory effect
05/30/2003WO2003044041A2 Alpha-fetoprotein peptides and uses for imaging
05/30/2003WO2003044040A2 Alpha-fetoprotein peptides and uses thereof
05/30/2003WO2003044039A2 Atrial natriuretic peptide clearance receptor variant associated with bone disorders
05/30/2003WO2003043986A1 Polypeptides of moraxella (branhamella) catarrhalis
05/30/2003WO2003043669A1 Composition and method for treatment of wounds
05/30/2003WO2003043654A1 Recombinant vaccinia virus vaccine
05/30/2003WO2003043649A1 Removal promoters and inhibitor for apoptosis cells in vivo
05/30/2003WO2003043588A1 Nonhuman model animal unresponsive to immunopotentiating synthetic compound
05/30/2003WO2003043587A2 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna
05/30/2003WO2003043565A2 Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
05/30/2003WO2003027248A3 Antibody inhibitors of gdf-8 and uses thereof
05/30/2003WO2003025176A3 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
05/30/2003WO2003016917A3 Sodium channel regulators and modulators
05/30/2003WO2003014327A3 Stress-related polynucleotides and polypeptides in plants
05/30/2003WO2003008448A3 Novel human proton-gated channels
05/30/2003WO2003004650A3 Group b streptococcus antigens and corresponding dna fragments
05/30/2003WO2003004006A3 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
05/30/2003WO2003001204A3 Type 1 diabetes diagnostics and therapeutics
05/30/2003WO2003000111A3 Human ugrp (uteroglobin-related protein) 1 promoter and its use
05/30/2003WO2002102853A3 Cd4-specific antibody trx1 and uses therefor
05/30/2003WO2002100898A3 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
05/30/2003WO2002100890A3 Respiratory syncytial virus
05/30/2003WO2002097059A3 Chromosome-based platforms
05/30/2003WO2002096952A3 Conjugate of a transport protein and a protein for modulation of notch signalling
05/30/2003WO2002095187A3 Methods of well treatment
05/30/2003WO2002095029A3 Nucleic acid and protein sequences of bovine epidermal growth factor
05/30/2003WO2002088176A3 Genes and proteins for the biosynthesis of polyketides
05/30/2003WO2002086068A3 Methods for producing recombinant coronavirus
05/30/2003WO2002085922A3 Proteins and nucleic acids encoding same
05/30/2003WO2002078426A3 Final segregation of male meiotic products in plants
05/30/2003WO2002077029A3 Cd19-specific redirected immune cells
05/30/2003WO2002076485A3 Vaccine for modulating between t1 and t2 immune responses
05/30/2003WO2002070738A3 Diagnosis and treatment of blood disorders
05/30/2003WO2002070020A3 Polymer precursors of radiolabeled compounds, and methods of making and using the same
05/30/2003WO2002068594A3 Opiate receptors
05/30/2003WO2002064790A3 Jfy1 protein induces rapid apoptosis
05/30/2003WO2002064621A3 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent
05/30/2003WO2002059293A3 Process and compositions for peptide, protein and peptidomimetic synthesis
05/30/2003WO2002057314A3 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes
05/30/2003WO2002053728A9 Gene disruption methodologies for drug target discovery
05/30/2003WO2002051868A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
05/30/2003WO2002044376A3 Modulation of gene expression using insulator binding proteins
05/30/2003WO2002038608A9 Methods of screening for ltrpc2 modulators
05/30/2003WO2002036816A3 Method of determining susceptibility to diseases
05/30/2003WO2002036160A3 Method for obtaining antigenic structures enhancing specific cross reactivity
05/30/2003WO2002034291A3 Compositions and methods for treating hematologic malignancies and multiple drug resistance
05/30/2003WO2002033065A3 Method for producing proteins by electroporation
05/30/2003WO2002030962A3 Metal binding proteins, recombinant host cells and methods
05/30/2003WO2002020790A9 Parietaria judaica ns-ltp antigen variants, uses thereof and compositions comprising them
05/30/2003WO2002018425A3 '47324', a novel g-protein and uses therefor
05/30/2003WO2002012273A3 Herbicide target genes and methods
05/30/2003WO2002008382A3 Controlled environment agriculture bioreactor for heterologous protein production
05/30/2003WO2002008270A3 A mort-1 interacting protein, its preparation and use
05/30/2003WO2002006328A3 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
05/30/2003WO2002000692A9 Pd-l2 molecules: pd-1 ligands and uses therefor
05/30/2003WO2001096381A3 IMMUNIZATION OF DAIRY CATTLE WITH GapC PROTEIN AGAINST STREPTOCOCCUS INFECTION
05/30/2003WO2001087922A3 Derivatisation of proteins in aqueous solution
05/30/2003CA2492536A1 Postsynaptic proteins
05/30/2003CA2468178A1 Method for producing l-amino acid using bacteria belonging to the genus escherichia
05/30/2003CA2468145A1 Transcriptional factors for the huntington's disease gene
05/30/2003CA2468088A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
05/30/2003CA2467958A1 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna
05/30/2003CA2467930A1 Treatment of pml targeting jc virus agno
05/30/2003CA2467927A1 Antimicrobial polypeptides from pseudoplectania nigrella
05/30/2003CA2467908A1 Mfg-e8-l regulates phagocytic removal of apoptotic cells by macrophages
05/30/2003CA2467756A1 Alpha-fetoprotein peptides and uses thereof
05/30/2003CA2467731A1 Chemically-modified human growth hormone conjugates
05/30/2003CA2467246A1 Composition and method for treatment of wounds
05/30/2003CA2467206A1 Genes encoding g-protein coupled receptors and methods of use therefor
05/30/2003CA2467053A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/30/2003CA2466937A1 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen
05/30/2003CA2464957A1 Polypeptides of moraxella (branhamella) catarrhalis
05/30/2003CA2464542A1 Composition comprising and method of using angiopoietin-like protein 3 angptl3
05/30/2003CA2445078A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof
05/30/2003CA2409500A1 Polynucleotide and protein involved in synaptogenesis, variants thereof, and their therapeutic and diagnostic applications
05/30/2003CA2407302A1 Genes transfection into bony tissues
05/29/2003US20030101489 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
05/29/2003US20030101488 Nucleotide sequences coding lyase for use in controlling aging and apoptosis in plants
05/29/2003US20030101486 Schizochytrium PKS genes
05/29/2003US20030101483 Regulatory nucleotide sequences for use in the generation of disease resistant plants
05/29/2003US20030101482 Compositions encoding lepidopteran-toxic polypeptides and methods of use
05/29/2003US20030101481 Polynucleotides for use as tool in the expression of heterologous metabolic proteins
05/29/2003US20030101479 Constitutive photomorphogenesis 1 (COP1) nucleic acid sequence from Zea mays and its use thereof
1 ... 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 ... 2916